IL-15 transpresentation by ovarian cancer cells improves CD34 <sup>+</sup> progenitor-derived NK cell's anti-tumor functionalityMarcos Vidal-Manrique, Harry Dolstra, Anniek B. van der Waart et al.|OncoImmunology|2025Cited by 10
Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trialJanneke S. Hoogstad‐van Evert, Harry Dolstra, Paul K.J.D. de Jonge et al.|Gynecologic Oncology|2025Cited by 6
Intraperitoneal Infusion of Stem Cell-Derived Natural Killer Cells in Recurrent Epithelial Ovarian Cancer Patients: Results of the Phase 1 INTRO-01 TrialJanneke Hoogstad, Harry Dolstra, Paul K.J.D. de Jonge et al.|SSRN Electronic Journal|2025Cited by 0